OREM, Utah., Nov. 16, 2021 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (OTCQB: RSCF), a provider of diverse products and services for biotechnology, pharmaceutical, and transportation industries, today announced financial results for the third quarter of 2021.
Mr. Boyce, CEO of Reflect Scientific Inc., commented, “Another profitable quarter for Reflect. We continue to improve cryogenic product line margins improving overall gross profit. In uncertain times we have proven our ability to deliver products and maintain positive financial results.”
The following unaudited table summarizes revenue, cost of goods sold, and operating expenses for the three and nine months ended September 30, 2021 and 2020:
REFLECT SCIENTIFIC, INC.
Condensed Consolidated Statements of Operations
(Unaudited)
| For the Three Months Ended | For the Nine Months Ended | ||||||||||||||||
| September 30, | September 30, | ||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | ||||||||||||||
| REVENUES | $ | 716,145 | $ | 610,085 | $ | 1,985,640 | $ | 2,096,799 | |||||||||
| COST OF GOODS SOLD | 242,343 | 252,112 | 621,317 | 845,281 | |||||||||||||
| GROSS PROFIT | 473,802 | 357,973 | 1,364,323 | 1,251,518 | |||||||||||||
| OPERATING EXPENSES | |||||||||||||||||
| Salaries and wages | 146,697 | 77,701 | 429,417 | 406,611 | |||||||||||||
| Research and development expense | 17,544 | 754 | 45,697 | 190,610 | |||||||||||||
| General and administrative expense | 149,672 | 75,330 | 422,036 | 309,836 | |||||||||||||
| Total Operating Expenses | 313,913 | 153,785 | 897,150 | 907,057 | |||||||||||||
| OPERATING INCOME (LOSS) | 159,889 | 204,188 | 467,173 | 344,461 | |||||||||||||
| OTHER INCOME (EXPENSE) | |||||||||||||||||
| Gain on forgiveness of SBA loan | – | – | 111,265 | – | |||||||||||||
| Other income | – | – | – | (132 | ) | ||||||||||||
| Total Other Income (Expenses) | – | – | 111,265 | (132 | ) | ||||||||||||
| NET INCOME (LOSS) BEFORE TAXES | 159,889 | 204,188 | 578,438 | 344,329 | |||||||||||||
| Income tax benefit (expense) | – | – | – | – | |||||||||||||
| NET INCOME (LOSS) | $ | 159,889 | $ | 204,188 | $ | 578,438 | $ | 344,329 | |||||||||
About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific’s products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses. Visit www.reflectscientific.com for more information. See us on Twitter @ReflectSci and LinkedIn www.linkedin.com/company/reflect-scientific.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the OTC Markets Group, LLC under the trading symbol “RSCF” and related prior filings by the Company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading “Disclosure,” including those identified in such filings as “forward-looking statements.”
CONTACT: Contact Thomas Tait 801-607-1039 investor_relations@reflectscientific.com
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI), a global leader in noninvasive…
Henry Charlton and Claire Poulard to join the Board of Directors Funding will Accelerate US…
NEW YORK, July 15, 2024 /PRNewswire/ -- The global trenbolone enanthate market size is estimated to grow by…
NEW YORK, July 15, 2024 /PRNewswire/ -- The global mindfulness meditation application market size is…
NextStep Arthropedix, a growing orthopedics company, announces the launch of TheRay™ Collared and Collarless Hip System.…
MILWAUKEE, WI / ACCESSWIRE / July 15, 2024 / SPS Health, a leading innovator in…